Contrast-zero transcatheter aortic valve replacement with ACURATE neo2™ system in patients with severe chronic kidney disease.

MLA

Ielasi, Alfonso, et al. “Contrast-Zero Transcatheter Aortic Valve Replacement with ACURATE Neo2™ System in Patients with Severe Chronic Kidney Disease.” Minerva Cardiology & Angiology, vol. 72, no. 2, Apr. 2024, pp. 212–13. EBSCOhost, https://doi.org/10.23736/S2724-5683.23.06338-X.

APA

Ielasi, A., Buono, A., Pellicano, M., Briguglia, D., Uccello, G., Cortese, B., De Blasio, G., Glauber, M., Guagliumi, G., & Tespili, M. (2024). Contrast-zero transcatheter aortic valve replacement with ACURATE neo2™ system in patients with severe chronic kidney disease. Minerva Cardiology & Angiology, 72(2), 212–213. https://doi.org/10.23736/S2724-5683.23.06338-X

Chicago

Ielasi, Alfonso, Andrea Buono, Mariano Pellicano, Daniele Briguglia, Giuseppe Uccello, Bernardo Cortese, Giuseppe De Blasio, Mattia Glauber, Giulio Guagliumi, and Maurizio Tespili. 2024. “Contrast-Zero Transcatheter Aortic Valve Replacement with ACURATE Neo2™ System in Patients with Severe Chronic Kidney Disease.” Minerva Cardiology & Angiology 72 (2): 212–13. doi:10.23736/S2724-5683.23.06338-X.